Acelrx Pharmaceuticals Inc
ACRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.58M
Close$
Share Statistics
| Market cap | $14.58 Million |
|---|---|
| Enterprise Value | $13.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.52 |
| Outstanding Shares | 75,526,900 |
Return
| Return on Equity | -104.65% |
|---|---|
| Return on Assets | -56.24% |
| Return on Invested Capital | -60.72% |
Valuation & Multiples
| P/E Ratio | -3.76 |
|---|---|
| PEG | -15.94 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 13836.98 |
| Enterprise Value to EBIT | -1.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acelrx Pharmaceuticals Inc
CEO: Vincent Angotti